Inventor · disambiguated record
Maria Antonia Wijdeven
Also filed as: WIJDEVEN MARIA ANTONIA
21 granted patents·16 pending applications·188 citations·filing 2013–2025
93Inventor score
Top patents by PatentIndex Score
37 records- 0198US9504758B2Modified antibody, antibody-conjugate and process for the preparation thereofSYNAFFIX BV·Filed 2015·Granted Nov 29, 2016·65 cites·20 claims
- 0297US10266502B2Process for the cycloaddition of a halogenated 1,3-dipole compound with a (hetero)cycloalkyneSYNAFFIX BV·Filed 2015·Granted Apr 23, 2019·78 cites·15 claims
- 0392US9636421B2Sulfamide linker, conjugates thereof, and methods of preparationSYNAFFIX BV·Filed 2016·Granted May 2, 2017·14 cites·15 claims
- 0491US11338043B2Antibody-conjugates with improved therapeutic index for targeting HER2 tumours and method for improving therapeutic index of antibody-conjugatesSYNAFFIX BV·Filed 2017·Granted May 24, 2022·8 cites·10 claims
- 0590US10072096B2Modified glycoprotein, protein-conjugate and process for the preparation thereofSYNAFFIX BV·Filed 2014·Granted Sep 11, 2018·9 cites·15 claims
- 0690US9988661B2Process for the modification of a glycoprotein using a glycosyltransferase that is or is derived from A β(1,4)-N-acetylgalactosaminyltransferaseSYNAFFIX BV·Filed 2016·Granted Jun 5, 2018·5 cites·11 claims
- 0788US10792369B2Sulfamide linker, conjugates thereof, and methods of preparationSYNAFFIX BV·Filed 2017·Granted Oct 6, 2020·3 cites·25 claims
- 0886US2025177554A1Modified antibody, antibody-conjugate and process for the preparation thereofSYNAFFIX BV·Filed 2024·Application pending·0 cites
- 0985US11850286B2Sulfamide linker, conjugates thereof, and methods of preparationSYNAFFIX BV·Filed 2020·Granted Dec 26, 2023·1 cites·28 claims
- 1083US9987373B2Modified glycoprotein, protein-conjugate and process for the preparation thereofSYNAFFIX BV·Filed 2014·Granted Jun 5, 2018·3 cites·19 claims
- 1182US11299759B2Process for the modification of a glycoprotein using a glycosyltransferase that is or is derived from a β(1,4)-n-acetylgalactosaminyltransferaseSYNAFFIX BV·Filed 2018·Granted Apr 12, 2022·1 cites·9 claims
- 1278US11951175B2Bioconjugates containing sulfamide linkers for use in treatmentSYNAFFIX BV·Filed 2017·Granted Apr 9, 2024·1 cites·21 claims
- 1374US12049656B2Process for the modification of a glycoprotein using a glycosyltransferase that is or is derived from a β(1,4)-n-acetylgalactosaminyltransferaseSYNAFFIX BV·Filed 2022·Granted Jul 30, 2024·0 cites·14 claims
- 1474US2024398971A1Bioconjugates containing sulfamide linkers for use in treatmentSYNAFFIX BV·Filed 2024·Application pending·0 cites
- 1572US2025304611A1Synthesis of 6-azido-6-deoxy-2-n-acetyl-hexosamine-nucleoside diphosphateSYNAFFIX BV·Filed 2025·Application pending·0 cites
- 1671US12194107B2Modified antibody, antibody-conjugate and process for the preparation thereofSYNAFFIX BV·Filed 2020·Granted Jan 14, 2025·0 cites·22 claims
- 1770US2023127659A1Antibody-conjugates with improved therapeutic index for targeting her2 tumours and method for improving therapeutic index of antibody-conjugatesSYNAFFIX BV·Filed 2022·Application pending·0 cites
- 1868US12281135B2Synthesis of 6-azido-6-deoxy-2-n-acetyl-hexosamine-nucleoside diphosphateSYNAFFIX BV·Filed 2022·Granted Apr 22, 2025·0 cites·20 claims
- 1968US11713453B2Enzymes for trimming of glycoproteinsSYNAFFIX BV·Filed 2020·Granted Aug 1, 2023·0 cites·18 claims
- 2065US2025090679A1Antibody-conjugates for targeting of tumours expressing trop-2SYNAFFIX BV·Filed 2024·Application pending·0 cites
- 2165US2023405143A1Tyrosine-based antibody conjugatesSYNAFFIX BV·Filed 2023·Application pending·0 cites
- 2263US2023226208A1Methods for the preparation of bioconjugatesSYNAFFIX BV·Filed 2023·Application pending·0 cites
- 2362US11957763B2Sulfamide linkers for use in bioconjugatesSYNAFFIX BV·Filed 2020·Granted Apr 16, 2024·0 cites·20 claims
- 2462US10745488B2Modified antibody, antibody-conjugate and process for the preparation thereofSYNAFFLIX BV·Filed 2013·Granted Aug 18, 2020·0 cites·35 claims
- 2561US2023330245A1Antibody-exatecan conjugatesSYNAFFIX BV·Filed 2023·Application pending·0 cites
- 2660US11590239B2Antibody-conjugates with improved therapeutic index for targeting CD30 tumours and method for improving therapeutic index of antibody-conjugatesSYNAFFIX BV·Filed 2017·Granted Feb 28, 2023·0 cites·9 claims
- 2759US2023364262A1Via cycloaddition bilaterally functionalized antibodiesSYNAFFIX BV·Filed 2022·Application pending·0 cites
- 2859US2019225706A1Modified glycoprotein, protein-conjugate and process for the preparation thereofSYNAFFIX BV·Filed 2018·Application pending·0 cites
- 2959US2023114866A1Via cycloaddition bilaterally functionalized antibodiesSYNAFFIX BV·Filed 2022·Application pending·0 cites
- 3059US2025262314A1Multifunctional antibodiesSYNAFFIX BV·Filed 2022·Application pending·0 cites
- 3158US10874746B2Sulfamide linkers for use in bioconjugatesSYNAFFIX BV·Filed 2017·Granted Dec 29, 2020·0 cites·14 claims
- 3258US2022096652A1Acetal-based cleavable linkersSYNAFFIX BV·Filed 2021·Application pending·0 cites
- 3357US10858641B2Enzymes for trimming of glycoproteinsSYNAFFIX BV·Filed 2017·Granted Dec 8, 2020·0 cites·15 claims
- 3454US12397063B2Antibody-conjugates for targeting of tumours expressing Trop-2SYNAFFIX BV·Filed 2021·Granted Aug 26, 2025·0 cites·21 claims
- 3554US2016235861A1Glycoengineered antibody, antibody-conjugate and methods for their preparationSYNAFFIX BV·Filed 2014·Application pending·0 cites
- 3649US2016257764A1Glycoengineered antibody, antibody-conjugate and methods for their preparationSYNAFFIX BV·Filed 2014·Application pending·0 cites
- 3736US2017009266A1Process for the attachment of a galnac moiety comprising a (hetero)aryl group to a glcnac moiety, and product obtained therebySYNAFFIX BV·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Maria Antonia Wijdeven files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →